Questioning The Controlled Substances Act After Enmon
By Jack Sharman, Brandon Essig and Jeff Doss, Lightfoot Franklin and White LLC (May 10, 2017, 12:31 PM EDT) -- With the Eleventh Circuit's recent decision in United States v. Enmon, physicians continue to face two critical questions in the uncertain case law under the federal Controlled Substances Act. First, what conduct is prohibited? Second, what intent must the physician be shown to possess in order to support a conviction? Given the government's increasingly aggressive prosecution of physicians with regard to controlled substances, white-collar practitioners who represent a physician or other healthcare professional in a "pill mill" case understand and address these issues in pretrial briefing and in preparing their trial strategy and must do so early....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!